Duracrin is a biotechnology company developing technologies or products in the life sciences sector.
Duracrin has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Duracrin is headquartered in New Haven, United States.
Duracrin is a biotechnology company developing technologies or products in the life sciences sector.
Duracrin is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Duracrin — Funding & Investors." VCBacked, February 16, 2026, https://www.vcbacked.co/company/duracrin. Accessed August 13, 2026.
VCBacked. (2026). Duracrin — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/duracrin
{{cite web |title=Duracrin — Funding & Investors |url=https://www.vcbacked.co/company/duracrin |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated